In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $6.52 in the last session, down -4.54% from day before closing price of $6.83. In other words, the price has decreased by -$4.54 from its previous closing price. On the day, 0.98 million shares were traded. EYPT stock price reached its highest trading level at $7.04 during the session, while it also had its lowest trading level at $6.44.
Ratios:
We take a closer look at EYPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.77 and its Current Ratio is at 7.81. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on January 07, 2025, initiated with a Buy rating and assigned the stock a target price of $33.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.Jefferies initiated its Buy rating on August 28, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 23 ’24 when ANTHONY P. ADAMIS bought 67,100 shares for $10.04 per share.
David R. Guyer bought 36,975 shares of EYPT for $329,817 on Oct 14 ’24. On Aug 20 ’24, another insider, DICICCO WENDY F, who serves as the Director of the company, bought 2,567 shares for $7.79 each. As a result, the insider paid 19,997 and bolstered with 9,967 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 448111776 and an Enterprise Value of 100303512. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.36 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at 2.318 whereas that against EBITDA is -0.695.
Stock Price History:
The Beta on a monthly basis for EYPT is 1.27, which has changed by -0.6938967 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, EYPT has reached a high of $23.97, while it has fallen to a 52-week low of $5.54. The 50-Day Moving Average of the stock is -9.47%, while the 200-Day Moving Average is calculated to be -24.38%.
Shares Statistics:
According to the various share statistics, EYPT traded on average about 861.11K shares per day over the past 3-months and 844380 shares per day over the past 10 days. A total of 68.27M shares are outstanding, with a floating share count of 59.62M. Insiders hold about 13.25% of the company’s shares, while institutions hold 96.88% stake in the company. Shares short for EYPT as of 1740700800 were 10734271 with a Short Ratio of 12.47, compared to 1738281600 on 10724031. Therefore, it implies a Short% of Shares Outstanding of 10734271 and a Short% of Float of 17.639999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
